Genmab reported 51M in Interest Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
BioMarin Pharmaceutical BMRN:US 2.5M 685K
Bluebird Bio BLUE:US 174K 68K
Exelixis EXEL:US 4.76M 2.94M
Fresenius Medical Care FME:GR 13M 1.11M
Genmab GEN:DC 51M 15M